Nanodiamonds

Research from University of Saskatchewan broadens understanding of nanodiamonds

Published in Biotech Business Week, July 5th, 2010

According to a study from Saskatoon, Canada, "Nanodiamond (ND) particles are biocompatible with no cytotoxicity to cells and have large surface area to provide high affinity to biomolecules. These properties make nanodiamond an ideal candidate for drug delivery."

"Protein pharmaceuticals have been becoming powerful and indispensable in combating human diseases due to the fact that they have high specificity and activity even at relatively low concentration. The present work deals with functionalization of nanodiamond particles for protein drug delivery applications. N,O-carboxymethyl chitosan (CMCS) is employed to modify the surface properties of pristine ND particles...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2010-07-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry